WCBA
Weaver C. Barksdale & Associates’s CVS Health CVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,007
| Closed | -$1.07M | – | 63 |
|
|
2024
Q3 | $1.07M | Sell |
17,007
-627
| -4% | -$39.4K | 0.96% | 55 |
|
|
2024
Q2 | $1.04M | Sell |
17,634
-250
| -1% | -$14.8K | 0.99% | 56 |
|
|
2024
Q1 | $1.42M | Sell |
17,884
-126
| -0.7% | -$10K | 1.31% | 46 |
|
|
2023
Q4 | $1.42M | Sell |
18,010
-4,512
| -20% | -$356K | 1.39% | 41 |
|
|
2023
Q3 | $1.57M | Buy |
22,522
+3,755
| +20% | +$262K | 1.34% | 46 |
|
|
2023
Q2 | $1.3M | Sell |
18,767
-1,132
| -6% | -$78.3K | 1.28% | 50 |
|
|
2023
Q1 | $1.48M | Sell |
19,899
-944
| -5% | -$70.1K | 1.38% | 47 |
|
|
2022
Q4 | $1.94M | Buy |
20,843
+533
| +3% | +$49.7K | 1.71% | 28 |
|
|
2022
Q3 | $1.94M | Sell |
20,310
-702
| -3% | -$67K | 1.94% | 9 |
|
|
2022
Q2 | $1.95M | Buy |
21,012
+1,391
| +7% | +$129K | 1.81% | 17 |
|
|
2022
Q1 | $1.99M | Sell |
19,621
-2,877
| -13% | -$291K | 1.77% | 21 |
|
|
2021
Q4 | $2.32M | Buy |
+22,498
| New | +$2.32M | 2.1% | 5 |
|
|
2017
Q4 | $1.51M | Buy |
20,860
+2,438
| +13% | +$177K | 1.59% | 29 |
|
|
2017
Q3 | $1.5M | Buy |
18,422
+915
| +5% | +$74.4K | 1.67% | 23 |
|
|
2017
Q2 | $1.41M | Hold |
17,507
| – | – | 1.64% | 24 |
|
|
2017
Q1 | $1.37M | Buy |
17,507
+4,700
| +37% | +$369K | 1.62% | 30 |
|
|
2016
Q4 | $1.01M | Buy |
+12,807
| New | +$1.01M | 1.63% | 13 |
|